| Prev Close | 0.40 |
| Open | 0.41 |
| Day Low/High | 0.40 / 0.48 |
| 52 Wk Low/High | 0.34 / 7.07 |
| Volume | 21.19M |
Endo International Plc (ENDP)
0.47
0.07
18.00
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 235.11B |
| Market Cap | 85.11M |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Premarket Movers
Upside - +17% (Chernin Group-led consortium confirms to acquire $263M in Funko) - +11% (earnings, guidance) - +10% (earnings) - +6.8% (earnings) - +5.2% (earnings, guidance) - +5.2% (earnings, guidance) - +4.6% (earnings, guidance) - +2.3% (earnings...
Premarket Movers
Upside - +74% (enters strategic agreement with Immune Therapeutics for rights to low dose naltrexone) - +18% (earnings, guidance) - +16% (earnings, guidance) - +14% (earnings) - +11% (earnings, guidance) - +10% (earnings, guidance) - +9.1% (highligh...
Biden Bits, Vaccine Vanguard, Unmasking Folly, Minerd Musings, Ives Inklings
Among other things, the president works to align Democratic senators to support his massive Covid relief bill.
Here's a Quartet of Small Biotechs That Could Make for Acquisition Targets
Merger activity is picking up this week in the biotechnology sector and these four promising companies would be good buyout candidates.
Trading Notes on 21 Stocks I Currently Own
Here are my takes on stocks in biotech and other companies I own right now.
10 Stocks With Attractive Charts in This Extended Market
As long as these charts hold up, I will continue to hold them regardless of what the indices might do.
'The Trend Is Your Friend'
The fact that the indices are so buoyant on the job news is an illustration of how much skepticism and fear there is.
9 Stocks on My Radar Into Earnings
Don't be too quick to turn negative if there are some pullbacks.
These Drug Cos. Could Soon Feel Big Side Effects of Opioid Crisis
No company is safe from the litigation risk tied to the drug epidemic, but Johnson & Johnson may be one of the few guaranteed to survive.
Johnson & Johnson Rises on $572 Million Fine That's Smaller Than Feared
Wall Street expects the healthcare giant can take the jolt from the penalty delivered by an Oklahoma judge in the state's opioid case against J&J.
3 Small Biotechs to Watch as Earnings Season Winds Down
One already is up nicely on its results, while the other two should issue reports of interest in the next few days.
3 Small Biotechs That Came Up Big on Thursday
Portola Pharmaceuticals, Flexion Therapeutics and BioDelivery Sciences delivered nice third-quarter numbers.
GoPro Is Among Seven Stocks Poised for a Reversal
These names are showing technical characteristics of either bullish or bearish reversal patterns.
4 Small-Caps on My Earnings Watch List
We are coming my favorite part of earnings season -- when these small-caps report.
3 Biotech Stocks on Readers' Minds
We answer questions about BioDelivery Sciences, Dynavax Technologies and Synergy Pharmaceuticals.
Trump's FDA: A Friendlier Biotech Sheriff
There still will be winners and losers, but the new administration's FDA is a net plus for the industry.
2 Recovering Biotech Names With Room to Run
There are reasons to believe rallies in BioDelivery Sciences and Flexion Therapeutics should continue.
Stepping Up to the Plate, Your Pinch Hitter, Bret Jensen!
As always, I am happy to stand in today for Doug Kass here at the Daily Diary. We already are at the midway point of June and coming up on the end of the first half of the year as well. The markets have provided solid returns to this point. although...
Uber's Quarterly Loss was a Staggering $708 Million, Key Exec Leaves
Uber's first quarter loss was less than the $991 million loss reported 3 months ago.
3 Small Biotech Value Plays
These stocks will be great stories in the second half of 2017, and are significantly undervalued.
These Stocks Show Change of Direction
Finding bullish and bearish reversals in the market.
Welcome to the Small-Cap Biotech Mailbag!
We answer recent reader questions about three of the biotech stocks we regularly cover.
BioDelivery Sciences Showing Strength
Not much action in the markets since our last update with the major indices continuing to grind slightly higher as we try to close out a solid first trading week of 2017 on a high note. Think Teva Pharmaceuticals getting oversold today on slightly r...
Cramer: Reviewing S&P's Hit-and-Miss Parade
Even among the losers, buys are scarce.
Make Sure Your Portfolio Is Protected From Volatility
If you use TVIX and VXX put in an above-market limit order, or if you trade options buy calls on the VIX.
3 Small-Cap Biotech Names for 2017
In our last post we discussed large-cap biotech names that have been beaten up in 2016, are cheap and hopefully will see better days in 2017. Here are a few small-cap biotechs I would keep an eye on in 2017. The following is a quick rundown. Aratana...
Bullish and Bearish Reversals in the Market
Which stocks have shown these patterns in the past week.
Biopharma: It's Darkest Before the Dawn
Thursday felt a lot like capitulation in this space. I was buying.
Trending Tickers: TWTR, VRX, ENDP, RIG
It appears Twitter will need more than takeover chatter to stay aloft, Oppenheimer analysts say.
